Cefuroxime
Cefuroxime for Injection USP and Dextrose Injection USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemoph…
United States
$67
per month
India
$2
per month
You save
−97%save $65/mo · 97% cheaper
1.1M US scripts/yr$74.6M potential annual savings$76.6M US spend/yr
Drag to rotate · 3D structureC16H16N4O8S
SMILES: CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
Compare the price
US price$67per month
India price$10per month
You save$5785% less
Based on 30 units per month. US $2.22 vs India $0.33 per unit.
Total over 1 periodSave $57$67 → $10
The bigger picture
Cefuroxime is filled about 1.1M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$76.6M
If sourced from India
$2M
Potential annual savings
$74.6M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.